Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.965 | 25 | 9 | 2006 | 2020 | ||||||||
|
CDK5 regulatory subunit associated protein 1 like 1 | 0.617 | 0.615 | 1.6E-02 |
|
disease | 0.700 | None | 0.984 | 21 | 86 | 2007 | 2019 | ||||||||
|
insulin like growth factor 2 mRNA binding protein 2 | 0.588 | 0.615 | 0.24 |
|
disease | 0.500 | None | 0.972 | 18 | 26 | 2007 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
disease | 0.500 | None | 0.972 | 18 | 15 | 2008 | 2019 | ||||||||
|
translocase of outer mitochondrial membrane 40 | 0.590 | 0.538 | 0.99 |
|
disease | 0.500 | None | 0.978 | 17 | 14 | 2009 | 2020 | ||||||||
|
solute carrier family 30 member 8 | 0.623 | 0.731 | 7.4E-12 |
|
disease | 0.500 | None | 0.963 | 15 | 3 | 2007 | 2019 | ||||||||
|
nectin cell adhesion molecule 2 | 0.575 | 0.769 | 0.97 |
|
disease | 0.440 | None | 1.000 | 14 | 20 | 2008 | 2019 | ||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.700 | None | 0.950 | 13 | 19 | 2006 | 2020 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.200 | None | 1.000 | 12 | 23 | 2007 | 2020 | |||||||||
|
complement factor H | 0.441 | 0.885 | 0.86 |
|
disease | 0.500 | None | 0.961 | 12 | 65 | 2005 | 2019 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 1.000 | moderate | 0.937 | 12 | 20 | 1998 | 2019 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.500 | None | 1.000 | 11 | 21 | 2005 | 2019 | |||||||||
|
potassium inwardly rectifying channel subfamily J member 11 | 0.529 | 0.615 | 1.1E-02 |
|
disease | 0.900 | strong | 0.943 | 11 | 3 | 1996 | 2019 | ||||||||
|
cancer susceptibility 16 | 0.780 | 0.308 |
|
disease | 0.200 | None | 1.000 | 11 | 4 | 2007 | 2020 | |||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.700 | None | 0.983 | 11 | 32 | 1997 | 2020 | ||||||||
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
disease | 0.500 | None | 0.954 | 11 | 16 | 2007 | 2020 | ||||||||
|
age-related maculopathy susceptibility 2 | 0.670 | 0.308 | 5.2E-04 |
|
disease | 0.700 | limited | 0.951 | 10 | 3 | 2005 | 2019 | ||||||||
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
disease | 0.500 | None | 0.953 | 10 | 58 | 2007 | 2020 | ||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.140 | None | 1.000 | 9 | 5 | 2007 | 2019 | |||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
disease | 0.100 | None | 1.000 | 9 | 12 | 2010 | 2018 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.942 | 9 | 11 | 1991 | 2020 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.700 | None | 0.899 | 9 | 4 | 2004 | 2019 | ||||||||
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
disease | 0.100 | None | 1.000 | 9 | 5 | 2007 | 2019 | ||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.140 | None | 1.000 | 9 | 5 | 2007 | 2019 | |||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
disease | 0.100 | None | 1.000 | 9 | 11 | 2007 | 2014 |